Responses
Cardiovascular medicine
Randomised double blind trial of oral versus intravenous flecainide for the cardioversion of acute atrial fibrillation
Compose a Response to This Article
Other responses
Jump to comment:
- Published on: 9 January 2022
- Published on: 9 January 2022IV and oral flecainide for the cardioversion of acute AFShow More
Dear Editor
I read, with great interest the article by Alp et al comparing intravenous and oral flecainide for the cardioversion of acute atrial fibrillation.[1] However, the article concludes that if a patient converts, there is no difference in the percentage of cardioversion by either route (even though the numbers presented tend to favour the oral route). But it fails to mention if there was any differences...
Conflict of Interest:
None declared.